While Copper Skin has been successful so far in Colombia, the initiative is now making its way to the 2024 Cannes Lions International Festival of Creativity.
SpringWorks Therapeutics addresses rare disease care gap in NF1-PN campaign
Launched on YouTube, Rare Connections in NMOSD seeks to raise awareness of the film through testimonials of three patients living with the rare inflammatory condition.
Healthcare brands, agencies and patients recognize Rare Disease Day 2024
In New York, the Empire State Building will be illuminated in a show of support, as will the Nasdaq MarketSite in Times Square and building 1 at the Food and Drug Administration headquarters in Jersey City, New Jersey.
Amgen details rare disease ambitions following $28B Horizon acquisition
“Most Likely Not To” will premiere at the Times Center in New York on February 29 — which is Rare Disease Day — and stars members of the SMA community, who also wrote the show.
Novartis unveils promising Fabhalta data for C3 glomerulopathy indication
Topline results from the Phase 3 trial, APPEAR-C3G, showed Fabhalta (iptacopan) met its primary endpoint in reducing protein in the urine in patients with C3G.
AI Deciphered: Discovering the Potential for Marketers and Communicators